EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Thermosensitive Hydrogel with Programmable, Self‐Regulated HIF‐1α Stabilizer Release for Myocardial Infarction Treatment

Kaicheng Deng, Yuyan Hua, Ying Gao, Houwei Zheng, Yangzi Jiang, Yaping Wang, Changyou Gao, Tanchen Ren, Yang Zhu iD

Advanced Science · 2024-11 · 11 (43)

DOI: 10.1002/advs.202408013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 23.09.2024. Verfasst von Kaicheng Deng und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Transvascular Implantation Devices, Department of Cardiology of The Second Affiliated Hospital, School of Medicine, Zhejiang …. Hauptthemen laut MEDLINE: Myocardial Infarction, Hypoxia-Inducible Factor 1, alpha Subunit, Hydrogels, Disease Models, Animal. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, State Key Laboratory of Transvascular Implantation Devices, China, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

HIF‐1α (hypoxia induced factor‐1α), a vital protective signal against hypoxia, has a short lifetime after myocardial infarction (MI). Increasing HIF‐1α stability by inhibiting its hydroxylation with prolyl hydroxylases inhibitors such as DPCA (1,4‐dihydrophenonthrolin‐4‐one‐3‐carboxylic acid) presents positive results. However, the optimal inhibitor administration profile for MI treatment is still unexplored. Here, injectable, thermosensitive hydrogels with programmable DPCA release are designed and synthesized. Hydrogel degradation and slow DPCA release are coupled to form a feedback loop by attaching pendant DPCA to polymer backbone, which serve as additional crosslinking points through π–π and hydrophobic interactions. Pendant carboxyl groups are added to the copolymer to accelerate DPCA release. Burst release in the acute phase for myocardial protection and extended near zero‐order release across the inflammatory and fibrotic phases with different rates are achieved. All DPCA‐releasing hydrogels upregulate HIF‐1α, decrease apoptosis, promote angiogenesis, and stimulate cardiomyocyte proliferation, leading to preserved cardiac function and ventricular geometry. Faster hydrogel degradation induced by faster DPCA release results in a HIF‐1α expression eight times of healthy control and better therapeutic effect in MI treatment. This research demonstrates the value of precise regulation of HIF‐1α expression in treating MI and other relevant diseases and provides an implantable device‐based modulation strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial InfarctionHypoxia-Inducible Factor 1, alpha SubunitHydrogelsDisease Models, AnimalAnimalsMiceMaleRatsHumansApoptosis

Stichwörter der Autor:innen

drug deliveryhydrogelhypoxia‐inducible factor‐1αmyocardial infarction

Substanzen

Hypoxia-Inducible Factor 1, alpha SubunitHydrogels

Autor:innen und Institutionen

  • State Key Laboratory of Transvascular Implantation Devices, Department of Cardiology of The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310009, China.
  • MOE Key Laboratory of Macromolecular Synthesis and Functionalization, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou, 310027, China.
  • Heart Regeneration and Repair Key Laboratory of Zhejiang Province, Hangzhou, 310009, China.
  • School of Biomedical Sciences, Institute for Tissue Engineering and Regenerative Medicine, The Chinese University of Hong Kong, Hong Kong Special Administrative Region of China, Hong Kong, 999077, China.
  • Key Laboratory for Regenerative Medicine, Ministry of Education, The Chinese University of Hong Kong, Hong Kong Special Administrative Region of China, Hong Kong, 999077, China.
  • Binjiang Institute of Zhejiang University, Hangzhou, 310053, China.

ORCID-Profile: Yang Zhu

Förderung

  • National Natural Science Foundation of China
  • State Key Laboratory of Transvascular Implantation Devices, China
  • Fundamental Research Funds for the Central Universities
  • Starry Night Science Fund of Zhejiang University Shanghai Institute for Advanced Study
  • Zhejiang Association for Science and Technology

Zitieren

APA

Deng, K., Hua, Y., Gao, Y., Zheng, H., Jiang, Y., Wang, Y., Gao, C., Ren, T., & Zhu, Y. (2024). Thermosensitive Hydrogel with Programmable, Self‐Regulated HIF‐1α Stabilizer Release for Myocardial Infarction Treatment. Advanced Science, 11(43). https://doi.org/10.1002/advs.202408013

Vancouver

Deng K, Hua Y, Gao Y, Zheng H, Jiang Y, Wang Y, et al. Thermosensitive Hydrogel with Programmable, Self‐Regulated HIF‐1α Stabilizer Release for Myocardial Infarction Treatment. Advanced Science. 2024;11(43). doi:10.1002/advs.202408013

BibTeX
@article{Deng2024,
  author = {Deng, Kaicheng and Hua, Yuyan and Gao, Ying and Zheng, Houwei and Jiang, Yangzi and Wang, Yaping and Gao, Changyou and Ren, Tanchen and Zhu, Yang},
  title = {Thermosensitive Hydrogel with Programmable, Self‐Regulated HIF‐1α Stabilizer Release for Myocardial Infarction Treatment},
  journal = {Advanced Science},
  year = {2024},
  volume = {11},
  number = {43},
  doi = {10.1002/advs.202408013}
}
Kostenlos starten →